Original Article
Copyright ©2010 Baishideng. All rights reserved
World J Gastroenterol. Jan 21, 2010; 16(3): 339-344
Published online Jan 21, 2010. doi: 10.3748/wjg.v16.i3.339
Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma
Yao Zheng, Lin Wang, Jian-Ping Zhang, Jing-Yan Yang, Zhu-Mei Zhao, Xiao-Ying Zhang
Yao Zheng, Lin Wang, Jian-Ping Zhang, Jing-Yan Yang, Zhu-Mei Zhao, Xiao-Ying Zhang, Department of Pathology, Shandong University School of Medicine, Jinan 250012, Shandong Province, China; Department of Pathology, Qilu Hospital of Shandong University, Jinan 250012, Shandong Province, China
Author contributions: Yang JY and Zhao ZM designed and performed the research; Zheng Y, Wang L and Zhang XY analyzed the data; Zheng Y and Zhang JP wrote the paper.
Supported by The Health Department of Shandong Province, No. T 47
Correspondence to: Jian-Ping Zhang, MD, Department of Pathology, Qilu Hospital of Shandong University, Jinan 250012, Shandong Province, China. jzhan3@yahoo.com
Telephone: +86-531-82169221 Fax: +86-531-88383168
Received: October 4, 2009
Revised: November 17, 2009
Accepted: November 24, 2009
Published online: January 21, 2010
Abstract

AIM: To compare two types of classification of intestinal metaplasia (IM) of the stomach and to explore their relationship to gastric carcinoma.

METHODS: Forty-seven cases of gastric IM were classified into type I, type II or type III according to mucin histochemical staining and compared with a novel classification in which the specimens were classified into simple IM (SIM) or atypical IM according to polymorphism in terms of atypical changes of the metaplastic epithelium. Forty-seven IM and thirty-seven gastric carcinoma samples were stained for p53, c-erbB-2 and Ki67 proteins by Envision immunohistochemical technique.

RESULTS: There were no significant differences in the expression of p53 and c-erbB-2 among type I, type II, type III IM and gastric carcinomas. The positive expression rate of Ki67 was significantly higher in gastric carcinomas than in type I IM while no significant Ki67 expression differences were observed among type II, type III IM and gastric carcinomas. The expression of p53, c-erbB-2 and Ki67 proteins in 20 SIM, 27 Atypical IM and 37 gastric carcinomas showed significant differences between SIM and gastric carcinomas while no significant differences were observed between Atypical IM and gastric carcinomas.

CONCLUSION: Atypical IM may better reveal the precancerous nature of IM and could be a helpful indicator in the clinical follow up of patients.

Keywords: Simple intestinal metaplasia, p53, Atypical intestinal metaplasia, c-erbB-2, Ki67